IL-12 cytokine factory demonstrates success in targeting hard-to-treat cancers

IL-12 cytokine factory demonstrates success in targeting hard-to-treat cancers

A team of researchers from the Rice Biotech Launch Pad at Rice University has developed an implantable "cytokine factory" that safely triggers potent immune res... Read More
ADS

Subscribe To Newsletter

Get The Information First

DISCLOSURE: We may earn a commission when you use one of our coupons/links to make a purchase.